AVAH Aveanna Healthcare Holdings, Inc.
Services-Home Health Care Services · Nasdaq · SEC CIK 1832332 · Fiscal year ends 01/01
Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY16.8%
TTM net income YoY305.7%
TTM EPS YoY278.4%
Revenue 3-yr CAGR12.7%
Net income 3-yr CAGR—
Margins
Gross margin32.3%
Operating margin11.4%
Net margin11.4%
FCF margin—
EBITDA margin11.8%
Returns
ROE176.7%
ROA15.2%
ROIC (approx.)23.4%
Asset turnover1.33x
Leverage & solvency
Liabilities / assets84.7%
Debt / equity3.84x
Current ratio1.23x
Interest coverage2.61x
Cash quality & payout
Operating cash flow / net income0.68x
Accruals ratio4.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-10-03 | 2026Q22026-07-04 | 2026Q12026-04-04 | 2026Q4*2026-01-03 | 2025Q32025-09-27 | 2025Q22025-06-28 | 2025Q12025-03-29 | 2024Q4*2024-12-28 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $695.54M | $670.48M | $647.91M | $662.48M | $621.94M | $589.55M | $559.22M | $519.87M |
| Cost of revenue | $468.77M | $451.96M | $442.49M | $449.18M | $419.12M | $378.75M | $375.67M | $348.15M |
| Gross profit | $226.76M | $218.53M | $205.43M | $213.30M | $202.82M | $210.80M | $183.56M | $171.72M |
| SG&A expense | $103.48M | $97.08M | $95.79M | $97.64M | $95.40M | $90.07M | $91.39M | $88.74M |
| Operating income | $83.56M | $79.98M | $69.33M | $71.05M | $53.58M | $80.03M | $51.80M | $45.77M |
| Interest expense | $27.09M | $27.78M | $29.16M | $32.62M | $35.13M | $36.00M | $36.34M | $38.10M |
| Pretax income | $64.78M | $56.47M | $44.98M | $39.24M | $13.42M | $44.14M | $10.15M | $26.93M |
| Income tax | $19.33M | $16.18M | $3.32M | -$139.51M | -$647,000 | $17.11M | $4.96M | -$2.25M |
| Net income | $45.45M | $40.29M | $41.65M | $178.75M | $14.06M | $27.02M | $5.19M | $29.18M |
| EBITDA | $86.72M | $82.83M | $72.37M | $73.77M | $56.18M | $82.65M | $54.40M | $48.22M |
| EPS (basic) | 0.21 | 0.19 | 0.19 | — | 0.07 | 0.13 | 0.03 | — |
| EPS (diluted) | 0.20 | 0.18 | 0.19 | — | 0.06 | 0.13 | 0.03 | — |
| Weighted avg. shares (diluted) | 229.22M | 224.86M | 222.10M | — | 222.23M | 210.44M | 206.24M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $197.84M | $97.20M | $189.27M | $193.26M | $145.87M | $100.74M | $71.49M | $84.29M |
| Receivables | $333.73M | $337.23M | $332.69M | $313.36M | $312.83M | $316.28M | $294.83M | $265.19M |
| Current assets | $565.88M | $478.09M | $575.30M | $560.23M | $502.60M | $449.92M | $407.62M | $392.67M |
| PP&E, net | $17.55M | $18.44M | $17.86M | $16.65M | $17.40M | $17.88M | $18.91M | $17.37M |
| Goodwill | $1.28B | $1.28B | $1.12B | $1.12B | $1.12B | $1.12B | $1.05B | $1.05B |
| Intangibles | $102.76M | $99.82M | $91.93M | $92.56M | $93.87M | $94.45M | $89.22M | $89.57M |
| Total assets | $2.21B | $2.11B | $2.02B | $2.01B | $1.81B | $1.77B | $1.66B | $1.66B |
| Current liabilities | $460.29M | $411.32M | $390.43M | $424.46M | $409.69M | $414.23M | $388.31M | $402.17M |
| Short-term debt | $13.18M | $13.25M | $13.25M | $13.25M | $13.25M | $9.20M | $9.20M | $9.20M |
| Long-term debt | $1.28B | $1.28B | $1.28B | $1.29B | $1.29B | $1.27B | $1.27B | $1.27B |
| Total debt | $1.30B | $1.30B | $1.30B | $1.30B | $1.30B | $1.28B | $1.28B | $1.28B |
| Total liabilities | $1.87B | $1.82B | $1.78B | $1.82B | $1.80B | $1.78B | $1.76B | $1.79B |
| Shareholders' equity | $337.42M | $287.28M | $240.05M | $194.46M | $9.18M | -$11.99M | -$100.13M | -$123.55M |
| Net debt | $1.10B | $1.20B | $1.11B | $1.11B | $1.16B | $1.18B | $1.21B | $1.20B |
| Shares outstanding | 218.39M | 218.15M | 217.51M | 211.00M | 208.91M | 208.26M | 195.09M | 193.23M |
| Cash flow statement | ||||||||
| Operating cash flow | $72.25M | $80.93M | $4.35M | $49.72M | $33.20M | $51.57M | -$8.63M | $13.41M |
| Investing cash flow | -$8.76M | -$175.37M | -$4.56M | -$1.95M | -$2.02M | -$15.98M | -$2.35M | -$1.53M |
| Financing cash flow | $37.16M | $2.36M | -$3.78M | -$377,000 | $13.95M | -$6.34M | -$1.81M | -$6.05M |
| Depreciation & amortization | $3.17M | $2.85M | $3.04M | $2.73M | $2.60M | $2.62M | $2.59M | $2.45M |
| Stock-based compensation | $4.24M | $4.13M | $4.15M | $3.95M | $4.96M | $5.16M | $11.00M | $4.98M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.